Which atypical antipsychotic!

被引：45
作者：
Thomas, CS [1 ]
Lewis, S [1 ]
机构：
[1] Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England
来源：
BRITISH JOURNAL OF PSYCHIATRY | 1998年 / 172卷
关键词：
D O I：
10.1192/bjp.172.2.106
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：106 / 109
页数：10
相关论文
共 32 条
  • [1] ADDINGTON DE, 1993, CLIN THER, V15, P917
  • [2] ALMOND S, 1998, IN PRESS J PHARMACOE
  • [3] Risperidone vs. haloperidol in treatment resistant schizophrenia
    Ames, D
    Wirshing, WC
    Marshall, BD
    Green, MF
    McGurk, SR
    Mintz, J
    Marder, SR
    [J]. SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 193 - 194
  • [4] ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784
  • [5] Multiple fixed doses of ''Seroquel'' (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
    Arvanitis, LA
    Miller, BG
    Borison, RL
    Pitts, WM
    Sharif, ZA
    Hamner, MB
    Herz, MI
    True, JE
    Velligan, D
    Knesevich, MA
    Small, J
    Steinbook, R
    Hertzman, M
    Keck, PE
    Newcomer, JW
    Grace, J
    Rotrosen, J
    Tandon, R
    Dott, SG
    Ferguson, JM
    Addington, DEN
    MacEwan, GW
    Nair, VNP
    Shriqui, CL
    Williams, R
    Daniel, DG
    Shehi, GM
    Patterson, WM
    Merideth, CH
    [J]. BIOLOGICAL PSYCHIATRY, 1997, 42 (04) : 233 - 246
  • [6] Barnett AA, 1996, LANCET, V348, P256, DOI 10.1016/S0140-6736(05)65549-3
  • [7] Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial
    Beasley, CM
    Sanger, T
    Satterlee, W
    Tollefson, G
    Tran, P
    Hamilton, S
    Green, A
    Dott, S
    Pfister, G
    Roxas, L
    Small, J
    Thomas, M
    Ames, D
    Schooler, N
    Baker, R
    Levine, R
    Fabre, L
    Friedel, R
    Safferman, A
    Lieberman, J
    Stahl, S
    [J]. PSYCHOPHARMACOLOGY, 1996, 124 (1-2) : 159 - 167
  • [8] Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial
    Beasley, CM
    Tollefson, G
    Tran, P
    Satterlee, W
    Sanger, T
    Hamilton, S
    Fabre, L
    Small, J
    Ereshefsky, L
    True, J
    Nemeroff, C
    Risch, SC
    Perry, PJ
    Potkin, SG
    Borison, RL
    James, S
    Meltzer, HY
    Iqbal, N
    Fann, WE
    Gewirtz, GR
    Landbloom, R
    RoyByrne, PP
    Tuason, VB
    Carman, JS
    Stokes, PE
    Williams, R
    Ancill, RJ
    MacEwan, GW
    Gujavarty, KS
    Jones, B
    Lohr, JB
    [J]. NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) : 111 - 123
  • [9] Bondolfi Guido, 1996, European Neuropsychopharmacology, V6, pS2
  • [10] BREIER A, 1994, AM J PSYCHIAT, V151, P20
1234